Mepolizumab-Related Blood Eosinophil Decreases Are Associated with Clinical Remission in Severe Asthmatic Patients: A Real-World Study
<b>Background</b>: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear. <b>Objective</b>: The aim of this study was to assess the relationship between mepolizumab-induced blood eosino...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2025-07-01
|
| Colecção: | Antibodies |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2073-4468/14/3/61 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|